Medication use in patients with restless legs syndrome compared with a control population


Department of Psychology and Brain Sciences, Johns Hopkins University, Baltimore, MD, USA.


Primary restless legs syndrome () is a sensorimotor disorder causing chronic sleep deprivation in those with moderate to severe symptoms. It has been associated with other medical conditions, such as high blood pressure, depression and attention deficit hyperactive disorder (ADHD). If these conditions are more prevalent for patients, then it would be expected patients would use relatively more of the medications treating these conditions. Current medication use was obtained from 110 patients and 54 age, race and gender-matched local-community controls. Each subject was diagnosed as primary or having no indications for by a clinician board-certified in sleep medicine. The group used more medications than the control group even when medications used for treating were excluded. Significantly more of the patients than controls used anti-depressants, gastro-intestinal (GI) medications and asthma/allergy medications. patients compared with those without are more likely to use medications not related to treating . Moreover they use medications for conditions that have not previously been considered related to , i.e. GI and asthma/allergy conditions.

Eur J Neurol. 2008 Jan;15(1):16-21. Epub 2007 Nov 14



Randy Clare

Randy Clare

Randy Clare brings to The Sleep and Respiratory Scholar more than 25 years of extensive knowledge and experience in the sleep and pulmonary function field. He has held numerous management positions throughout his career and has demonstrated a unique view of the alternate care diagnostic and therapy model. He is considered by many an expert in the use of oral appliances like Silent Nite, EMA and TAP to treat snoring and sleep apnea in the dental office. Mr. Clare's extensive sleep industry experience assists Sleepandrespiratoryscholar in providing current, relevant, data-proven information on sleep diagnostics and sleep therapies that are effective for the treatment of sleep disorders. Mr Clare is director of business development for Glidewell a dental solutions company his focus is on dental treatment for sleep disordered breathing.

More Posts - Website

Follow Me:
TwitterFacebookLinkedInGoogle Plus

Leave a Reply